MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Pulmonology (Drugs, Pharmaceuticals, Biotechnology & Biosimilars)
Tvardi Therapeutics (NASDAQ: TVRD)
Organization & Developments: Tvardi Therapeutics
Parents
Tvardi Therapeutics (NASDAQ: TVRD)
Children
*Company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases.
*Product candidates include TTI-101 for idiopathic pulmonary fibrosis (IPF) and hepatocellular carcinoma (HCC) and TTI-109
Jumps
Finance & Acquisition: Tvardi Therapeutics
Key People: Tvardi Therapeutics